Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gilead Ends a Phase 2 Study for Antibody
Gilead Ends a Phase 2 Study for Antibody
Gilead Ends a Phase 2 Study for Antibody
Submitted by
admin
on January 6, 2016 - 8:00pm
Source:
WSJ Online
News Tags:
Gilead Sciences
simtuzumab
pancreatic cancer
Headline:
Gilead Ends a Phase 2 Study for Antibody
Do Not Allow Advertisers to Use My Personal information
